Literature DB >> 29974163

[Atypical distal tibial shaft fractures in a patient with bilateral TKA and antiresorptive treatment].

R Schimpf1, H Siekmann2, C Bauer3, F Radetzki4.   

Abstract

There are many cases in the literature that describe atypical femur fractures under antiresorptive therapy. Other localizations of fractures of this genesis, especially if occurring bilaterally, are rare. This case reports about the diagnosis, treatment and process of a 76-year old patient, who within a 4‑month period suffered from bilateral distal tibial shaft fractures, after years of treatment with bisphosphonates, strontium ranelate and denosumab.

Entities:  

Keywords:  Antiresorptive drugs; Bisphosphonates; Denosumab; Knee arthroplasty, total; Osteoporosis

Mesh:

Substances:

Year:  2018        PMID: 29974163     DOI: 10.1007/s00132-018-3596-6

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  13 in total

1.  Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation.

Authors:  Denise M van de Laarschot; M Carola Zillikens
Journal:  Bone       Date:  2016-07-29       Impact factor: 4.398

Review 2.  What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?

Authors:  P D Miller; R J Derman
Journal:  Osteoporos Int       Date:  2010-03-23       Impact factor: 4.507

3.  Medication management after intramedullary nailing of atypical fractures.

Authors:  Jean-Marc Feron; Adeline Cambon-Binder
Journal:  Injury       Date:  2017-04-26       Impact factor: 2.586

4.  Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy.

Authors:  Michael D Breglia; John D Carter
Journal:  J Clin Rheumatol       Date:  2010-03       Impact factor: 3.517

Review 5.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741

6.  A case of an unusual subtrochanteric fracture in a patient receiving denosumab.

Authors:  Rodis Paparodis; Bjoern Buehring; Elaine M Pelley; Neil Binkley
Journal:  Endocr Pract       Date:  2013 May-Jun       Impact factor: 3.443

7.  Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.

Authors:  Lyne Bissonnette; Pierre-Marc April; Réjean Dumais; Gilles Boire; Sophie Roux
Journal:  Bone       Date:  2013-07-17       Impact factor: 4.398

8.  Healing Time and Complications in Operatively Treated Atypical Femur Fractures Associated With Bisphosphonate Use: A Multicenter Retrospective Cohort.

Authors:  Yelena Bogdan; Paul Tornetta; Thomas A Einhorn; Pierre Guy; Lise Leveille; Juan Robinson; Michael J Bosse; Nikkole Haines; Daniel Horwitz; Clifford Jones; Emil Schemitsch; Claude Sagi; Bryan Thomas; Daniel Stahl; William Ricci; Megan Brady; David Sanders; Michael Kain; Thomas F Higgins; Cory Collinge; Stephen Kottmeier; Darin Friess
Journal:  J Orthop Trauma       Date:  2016-04       Impact factor: 2.512

Review 9.  Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).

Authors:  E Hernlund; A Svedbom; M Ivergård; J Compston; C Cooper; J Stenmark; E V McCloskey; B Jönsson; J A Kanis
Journal:  Arch Osteoporos       Date:  2013-10-11       Impact factor: 2.617

10.  A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate.

Authors:  Hanh H Nguyen; Frances Milat; Peter R Ebeling
Journal:  Bone Rep       Date:  2017-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.